High molecular weight adiponectin

1. Tirzepatide increases high molecular weight adiponectin in humans (78.9% and 88.4% vs 0.9%).

   Human trialobesity disease without diabetesweek 72n = 225

   Changes in Abdominal Adiposity and Associations With Metabolic Health Markers Following Tirzepatide in Japanese Participants With Obesity Disease: Results From the SURMOUNT-J Study · Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 19 Sep 2026

Tirzepatide →